Xenetic Biosciences Correlations

XBIO Stock  USD 3.37  0.03  0.88%   
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xenetic Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xenetic Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Xenetic Biosciences Correlation With Market

Significant diversification

The correlation between Xenetic Biosciences and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Xenetic Biosciences and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xenetic Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Xenetic Stock, please use our How to Invest in Xenetic Biosciences guide.

Moving together with Xenetic Stock

  0.69CMND Clearmind Medicine CommonPairCorr
  0.61MLSS Milestone Scientific Earnings Call This WeekPairCorr
  0.62HD Home DepotPairCorr

Moving against Xenetic Stock

  0.47PG Procter GamblePairCorr
  0.34LUCD Lucid DiagnosticsPairCorr
  0.42JNJ Johnson JohnsonPairCorr
  0.39T ATT Inc Earnings Call TodayPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
ATNFIMMX
REVBIMMX
ZVSARNAZ
PHIOZVSA
REVBATNF
IMMXZVSA
  
High negative correlations   
REVBRNAZ
REVBNAVB
NAVBATNF
NAVBPHIO
NAVBIMMX
NAVBZVSA

Risk-Adjusted Indicators

There is a big difference between Xenetic Stock performing well and Xenetic Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Xenetic Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
RNAZ  10.83 (1.19) 0.00 (0.35) 0.00 
 45.13 
 94.32 
LABP  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
NEXI  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ONCR  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ZVSA  4.67 (0.29) 0.00 (0.82) 0.00 
 12.03 
 38.26 
IMMX  3.38 (0.09) 0.00 (8.37) 0.00 
 6.82 
 26.42 
PHIO  11.03  2.00  0.17  0.42  9.59 
 9.40 
 336.29 
ATNF  4.42 (0.41) 0.00 (0.38) 0.00 
 7.62 
 79.11 
NAVB  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
REVB  5.58 (0.68) 0.00 (1.73) 0.00 
 11.78 
 66.25 

Xenetic Biosciences Corporate Executives

Elected by the shareholders, the Xenetic Biosciences' board of directors comprises two types of representatives: Xenetic Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Xenetic. The board's role is to monitor Xenetic Biosciences' management team and ensure that shareholders' interests are well served. Xenetic Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Xenetic Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
James ParslowCFO, Principal Accounting Officer, Principal Financial OfficerProfile